A detailed history of Rothschild Investment LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 108,254 shares of ABBV stock, worth $18.2 Million. This represents 1.4% of its overall portfolio holdings.

Number of Shares
108,254
Previous 110,514 2.04%
Holding current value
$18.2 Million
Previous $19 Billion 12.78%
% of portfolio
1.4%
Previous 1.32%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $370,278 - $450,485
-2,260 Reduced 2.04%
108,254 $21.4 Billion
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $17.1 Million - $20 Million
110,514 New
110,514 $19 Billion
Q1 2024

Jul 31, 2024

SELL
$159.82 - $182.1 $57,535 - $65,556
-360 Reduced 0.3%
118,903 $21.7 Billion
Q4 2023

Jul 31, 2024

BUY
$137.6 - $154.97 $1.2 Million - $1.36 Million
8,749 Added 7.92%
119,263 $18.5 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.